Affordable Access

The adaptive immune response to colorectal cancer: from the laboratory to clinical practice

Publication Date
  • R Medicine (General)
  • Rc0254 Neoplasms. Tumors. Oncology (Including Cancer)
  • Medicine


An increasing body of evidence supports that visibility of colorectal cancer to immune attack is substantial and that it limits disease progression. Analysis of the adaptive immune infiltrate in resected colorectal cancer specimens offers prognostic information which is independent of conventionally measured parameters and potentially superior in predictive value.

There are no comments yet on this publication. Be the first to share your thoughts.